Target of γ-secretase modulators, presenilin marks the spot Journal Article


Authors: Crump, C. J.; Johnson, D. S.; Li, Y. M.
Article Title: Target of γ-secretase modulators, presenilin marks the spot
Abstract: γ-Secretase modulators, or GSMs, which reduce the production of Aβ42, have emerged as a promising class of compounds for the treatment of Alzheimer's disease (AD). The target and mechanism of action of GSMs have been controversial as of late, with some evidence suggesting that GSMs function by binding the substrate, amyloid precursor protein (APP), and others claiming action through direct modulation of the enzyme, γ-secretase. In this issue of The EMBO Journal, Ohki et al (2011) show that piperidine acetic acid-based GSMs directly bind to presenilin, the catalytic subunit of γ-secretase; and GSM binding induces conformational changes in γ-secretase, leading to a shift in the cleavage site specificity of APP from longer to shorter peptide fragments. © 2011 European Molecular Biology Organization | All Rights Reserved.
Keywords: unclassified drug; nonhuman; protein conformation; animals; ibuprofen; nonsteroid antiinflammatory agent; peptide fragments; piperidines; drug protein binding; alzheimer disease; amyloid precursor protein; amyloid precursor protein secretases; presenilin; gamma secretase; presenilin-1; acetic acid derivative; allosteric regulation; piperidine derivative; avagacestat; central nervous system agents; gamma secretase modulator; imidazole; piperidine acetic acid; semagacestat; sulindac sulfide; amyloid beta-peptides
Journal Title: EMBO Journal
Volume: 30
Issue: 23
ISSN: 0261-4189
Publisher: Wiley Blackwell  
Date Published: 2011-11-30
Start Page: 4696
End Page: 4698
Language: English
DOI: 10.1038/emboj.2011.410
PROVIDER: scopus
PMCID: PMC3242977
PUBMED: 22126818
DOI/URL:
Notes: --- - "Export Date: 3 January 2012" - "CODEN: EMJOD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yueming Li
    132 Li
  2. Christina J Crump
    12 Crump